Surprisingly, pharmacologic inhibition of IL-6 by administration of a neutralizing antibody during the early phase increased apoptosis in AECII cells, neutrophil infiltration to the lung and fibrosis development, whereas IL-6 inhibition during the second phase ameliorated pulmonary fibrosis [218]. Here, IL6 is linked to fibrosis.